LEADING THE WAY IN CELL THERAPY

About MedXCell Science

MedXCell Science is a French Life science company active in the field of regenerative medicine. With the CHU of Montpellier as a shareholder and leveraging on its expertise, it is currently completing a clinical trial phase 2 (ADIPOA-2) for its allogeneic cell therapy treating mild to moderate knee osteoarthritis.

MedXCell Science results from the meeting between the University professor Christian Jorgensen (CHU Montpellier) and the entrepreneur Laurent Zbinden. The two founded MedXCell Science in 2018 together with the CHU of Montpellier, Prof. Noël and Prof. De Vos.

“Our ambition is to become the leader in providing cell-therapy products for sports medicine and the fight against ageing.”

Christian Jorgensen & Laurent Zbinden

Founders

Our Vision

Help people enjoy a better, longer and healthier life

Our Mission

Develop and deliver innovative cell therapy treatments that improve people’s quality of life and mobility

Our Values

Innovation

We continuously strive to find disruptive and innovative solutions

Ethical

Human respect and ethics - no dedicated tissue harvesting

Patient Centered

We develop affordable therapies that make a real and positive difference to the greatest number of patients

Passion

We are committed in heart and mind to what we do

Management Team

Mr Laurent Zbinden

Chairman & Co-Founder

Specialist in structuring companies. Entrepreneur and former CEO of companies with 30+ years experience.

Mr Patrice Lüthi

Chief Executive Officer

Former leader of industrial activities in the luxury industry (LVMH, Swatch) with 30+ years experience.

Dr Claire Gondeau

Chief Scientific Officer

Former research engineer in public research institutes (CNRS and INSERM) with 20+ years experience.

Dr Marc Criton

Business Developer
26+ years experience in pharmaceutical industry. Former assistant professor (UNIGE).

Dr Alan Cookson

Chief Technology & Innovation Officer
40+ years experience in pharmaceutical and healthcare. Founder of multiple biotech start-ups.

Mr. Lionel Brodard

Chief Financial Officer

Experienced in start-ups and biotech with background in Financial Engineering.

R&D Team

Prof. Christian Jorgensen

Co-Founder

Rheumatologist. Initiator & Director of the Institute of Regenerative Medicine & Biotherapy (IRMB) located in the CHU of Montpellier.

Prof. Danièle Noël

Co-Founder

Research Director at the INSERM U1183 Laboratory. Specialist in cell therapy. Authored more than 160 publications.

Prof. John de Vos

Co-Founder

Coordinator of the cellular and tissue engineering department of the CHU of Montpellier. Originator of stem cells and cellular therapies.